Zika, Ebola, and the Future of Other Public Health Diseases Discussed at Fortune Brainstorm Health Live Tomorrow

Primary tabs

Zika, Ebola, and the Future of Other Public Health Diseases Discussed at Fortune Brainstorm Health Live Tomorrow

Join public health panel from GSK, Time, and the Center for Infectious Disease Research and Policy at the University of Minnesota as they discuss the future of tracking emerging diseases
tweet me:
Join public health panel from #GSK @TimeHealth and @UMNewsas they discuss the future of tracking emerging diseases http://bit.ly/2faObmJ
Monday, October 31, 2016 - 7:00pm

CONTENT: Multimedia with summary

Just a few months after the 2015 outbreak of Ebola was contained, another virus—called Zika—commanded the public stage. It took but 14 months after Zika’s first detection in Brazil for the virus to spread through Latin America and the Caribbean to Florida. So far, the threat has gone unchecked. And to be sure, after Zika, will come another global pathogenic threat—one, that public health experts worry, may do an even better job of outsmarting and overwhelming us. The question is whether technological advances can help us turn the odds. Can big data and genomic virus sequencing help us track emerging diseases, contain their spread and ultimately find antidotes for the next unknown pathology? Can it speed up the hunt for lifesaving vaccinations or drugs? The answers have an urgency like few others.

Follow along live here at 7:30 EST/4:30 PST on November 1st

Keywords: Health & Healthcare | Events, Media & Communications | Fortune Brainstorm Health | GSK | GlaxoSmithKline | Moncef Slaoui | Zika | ebola | public health

CONTENT: Multimedia with summary